Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults.

NCT03154515 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT03154515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03154515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Double Blind Placebo Controlled Multicenter Study for Evaluation of Clinical Efficacy and Safety of Ingavirin 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections in Adults.
Lead sponsor
Valenta Pharm JSC
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
October 31, 2014
Enrollment
445 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory infection, common cold, influenza, human